
Keywords: CCA; cholangiocarcinoma; CT; computerized axial tomography; CCND; cyclin D; DMSO; dimethyl sulfoxide; ELISPOT; enzyme linked immune-spot assay; FFPE; formaldehyde fixed-paraffin embedded tissue; FPKM; fragments per kilobase mapped; 18FDG; fluorodeoxygluco